21 results on '"Tuchman, Sascha"'
Search Results
2. Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
3. Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma
4. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders
5. P-282: Addition of ixazomib to pomalidomide-dexamethasone improves progression-free survival for myeloma patients progressing on frontline lenalidomide: results of the randomized alliance study A061202
6. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status
7. The Spectrum of Monoclonal Immunoglobulin-Associated Diseases
8. Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment
9. MM-096: Isatuximab Short-Duration Fixed-Volume Infusion Combination Therapy for Relapsed/Refractory Multiple Myeloma: Final Results of a Phase 1b Feasibility/Safety Study
10. A comparison of three different approaches to defining frailty in older patients with multiple myeloma
11. Isatuximab short duration fixed volume infusion combination therapy for relapsed/refractory multiple myeloma (RRMM): phase 1b feasibility/safety study
12. Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
13. Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM)
14. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study
15. Access to NCI Comprehensive Cancer Centers among Patients with Multiple Myeloma: An Opportunity to Address Transplant Underutilization and Long Term Outcomes
16. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
17. Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone (“VCD-Lite”) in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma
18. Efficacy of Autologous Stem Cell Transplantation in Older Multiple Myeloma Patients
19. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults
20. Quantitative Measures of Physical Functioning After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Feasibility Study
21. High-Risk Multiple Myeloma: Does it Still Exist?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.